Connection

Michael Wyatt to Rituximab

Back to Details
This is a "connection" page, showing publications Michael Wyatt has written about Rituximab.
Michael Wyatt
Connection Strength
0.045
Rituximab
  1. Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions. Lancet Oncol. 2020 12; 21(12):e575-e588.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.